Available in select U.S. states. Eligibility is determined by the provider. Compounded semaglutide and tirzepatide are not FDA-approved for weight loss.
It is prescribed only when deemed medically appropriate by a licensed provider after review. Individual results vary significantly based on factors like adherence,
diet, exercise, and health status. No guarantees of weight loss. GLP-1 medications like semaglutide may increase the risk of thyroid C-cell tumors based on animal studies;
human risk is not confirmed. Services provided by licensed physicians/nurse practitioners in states served, e.g., CA, FL, and others, via telemedicine.
Check your state's telemedicine laws. Must be 18+ or Older to Qualify for Treatment. We prioritize your privacy and comply with HIPAA regulations for protected health information.
